153 related articles for article (PubMed ID: 17201146)
1. Analyses of promoter hypermethylation for RUNX3 and other tumor suppressor genes in nasopharyngeal carcinoma.
Tan SH; Ida H; Goh BC; Hsieh W; Loh M; Ito Y
Anticancer Res; 2006; 26(6B):4287-92. PubMed ID: 17201146
[TBL] [Abstract][Full Text] [Related]
2. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma.
Kwong J; Lo KW; To KF; Teo PM; Johnson PJ; Huang DP
Clin Cancer Res; 2002 Jan; 8(1):131-7. PubMed ID: 11801549
[TBL] [Abstract][Full Text] [Related]
3. Detection of promoter hypermethylation in serum samples of cancer patients by methylation-specific polymerase chain reaction for tumour suppressor genes including RUNX3.
Tan SH; Ida H; Lau QC; Goh BC; Chieng WS; Loh M; Ito Y
Oncol Rep; 2007 Nov; 18(5):1225-30. PubMed ID: 17914577
[TBL] [Abstract][Full Text] [Related]
4. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T
Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310
[TBL] [Abstract][Full Text] [Related]
5. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
Kao RH; Huang LC; Hsu YH
Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
[TBL] [Abstract][Full Text] [Related]
6. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
7. Patterns of aberrant DNA hypermethylation in nasopharyngeal carcinoma in Tunisian patients.
Challouf S; Ziadi S; Zaghdoudi R; Ksiaa F; Ben Gacem R; Trimeche M
Clin Chim Acta; 2012 Apr; 413(7-8):795-802. PubMed ID: 22296674
[TBL] [Abstract][Full Text] [Related]
8. Promoter CpG methylation of tumor suppressor genes in colorectal cancer and its relationship to clinical features.
Lin SY; Yeh KT; Chen WT; Chen HC; Chen ST; Chiou HY; Chang JG
Oncol Rep; 2004 Feb; 11(2):341-8. PubMed ID: 14719065
[TBL] [Abstract][Full Text] [Related]
9. Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines.
Ku JL; Kang SB; Shin YK; Kang HC; Hong SH; Kim IJ; Shin JH; Han IO; Park JG
Oncogene; 2004 Sep; 23(40):6736-42. PubMed ID: 15273736
[TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation of the RUNX3 gene in esophageal squamous cell carcinoma.
Long C; Yin B; Lu Q; Zhou X; Hu J; Yang Y; Yu F; Yuan Y
Cancer Invest; 2007 Dec; 25(8):685-90. PubMed ID: 18058463
[TBL] [Abstract][Full Text] [Related]
11. RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progression.
Subramaniam MM; Chan JY; Soong R; Ito K; Ito Y; Yeoh KG; Salto-Tellez M; Putti TC
Breast Cancer Res Treat; 2009 Jan; 113(1):113-21. PubMed ID: 18256927
[TBL] [Abstract][Full Text] [Related]
12. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma.
Lo KW; Kwong J; Hui AB; Chan SY; To KF; Chan AS; Chow LS; Teo PM; Johnson PJ; Huang DP
Cancer Res; 2001 May; 61(10):3877-81. PubMed ID: 11358799
[TBL] [Abstract][Full Text] [Related]
13. Differential gene methylation in undifferentiated nasopharyngeal carcinoma.
Wong TS; Tang KC; Kwong DL; Sham JS; Wei WI; Kwong YL; Yuen AP
Int J Oncol; 2003 Apr; 22(4):869-74. PubMed ID: 12632081
[TBL] [Abstract][Full Text] [Related]
14. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
Jiang Y; Tong D; Lou G; Zhang Y; Geng J
Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
[TBL] [Abstract][Full Text] [Related]
15. Promoter methylation status of multiple genes in uveal melanoma.
Merhavi E; Cohen Y; Avraham BC; Frenkel S; Chowers I; Pe'er J; Goldenberg-Cohen N
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4403-6. PubMed ID: 17898258
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic inactivation of the RUNX3 gene in lung cancer.
Sato K; Tomizawa Y; Iijima H; Saito R; Ishizuka T; Nakajima T; Mori M
Oncol Rep; 2006 Jan; 15(1):129-35. PubMed ID: 16328045
[TBL] [Abstract][Full Text] [Related]
17. Aberrant methylation of p16, DLEC1, BLU and E-cadherin gene promoters in nasopharyngeal carcinoma biopsies from Tunisian patients.
Ayadi W; Karray-Hakim H; Khabir A; Feki L; Charfi S; Boudawara T; Ghorbel A; Daoud J; Frikha M; Busson P; Hammami A
Anticancer Res; 2008; 28(4B):2161-7. PubMed ID: 18751390
[TBL] [Abstract][Full Text] [Related]
18. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK
Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230
[TBL] [Abstract][Full Text] [Related]
19. [Promoter methylation and expression of Runx3 gene in gastric cancer].
Li LY; Li JK; Shen Y; Yu L; Zhang JH
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul; 11(4):379-82. PubMed ID: 18636364
[TBL] [Abstract][Full Text] [Related]
20. RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors.
Kim WJ; Kim EJ; Jeong P; Quan C; Kim J; Li QL; Yang JO; Ito Y; Bae SC
Cancer Res; 2005 Oct; 65(20):9347-54. PubMed ID: 16230397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]